Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17568-17577
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17568
Table 1 International Classification of Diseases Codes and Canadian Classification of Health Interventions codes used to define outcomes or procedures
ICD-10 codes used to define perforation with UGIB secondary to PUD
Perforated ulcerK25.2, K25.6, K26.2, K26.6, K27.2, K27.6, K28.2, K28.6
Non-perforated ulcerK25.0, K25.4, K26.0, K26.4, K27.0, K27.4, K28.0, K28.4
CCI codes used to define surgery
Stomach repair1.NF.80.DA, 1.NF.80.DA-XX-E, 1.NF.80.DA-XX-N, 1.NF.80.LA, 1.NF.80.LA-XX-E, 1.NF.80.LA-XX-N
Partial excision of stomach1.NF.87.BA, 1.NF.87.DA, 1.NF.87.DG, 1.NF.87.DH, 1.NF.87.DJ, 1.NF.87.DL, 1.NF.87.DQ, 1.NF.87.GX, 1.NF.87.LA, 1.NF.87.RG, 1.NF.87.RH, 1.NF.87.RJ, 1.NF.87.RK, 1.NF.87.RP, 1.NF.87.SH
Total excision of stomach1.NF.89.DZ, 1.NF.89.GW, 1.NF.89.SG, 1.NF.89.TH
Small intestine repair1.NK.80.DA, 1.NK.80.DA-W2, 1.NK.80.DA-XX-E, 1.NK.80.LA, 1.NK.80.LA-W2, 1.NK.80.LA-XX-E
Partial excision of small intestine1.NK.87.BA, 1.NK.87.DA, 1.NK.87.DN, 1.NK.87.DP, 1.NK.87.DX, 1.NK.87.DY, 1.NK.87.LA, 1.NK.87.RE, 1.NK.87.RF, 1.NK.87.TF, 1.NK.87.TG
CCI codes used to define interventional radiology
Control of bleeding in stomach using percutaneous transluminal (transarterial) approach1.NF.13.GP-C2, 1.NF.13.GP-GE, 1.NF.13.GP-WO
Control of bleeding in small and large intestine using percutaneous transluminal (transarterial) approach1.NP.13.GQ-C2, 1.NP.13.GQ-GE, 1.NP.13.GQ-WO
CCI codes used to define an upper endoscopic procedure
Control of bleeding in stomach1.NF.13.BA, 1.NF.13.BA-AG, 1.NF.13.BA-BD, 1.NF.13.BA-C2, 1.NF.13.BA-FA, 1.NF.13.BA-GX, 1.NF.13.BA-KK, 1.NF.13.BA-W4, 1.NF.13.BA-X7
Stomach repair1.NF.80.BA
Inspection or biopsy of stomach2.NF.70.BA, 2.NF.70.BN, 2.NF.71.BA, 2.NF.71.BP, 2.NF.71.BR
Inspection or biopsy of small intestine2.NK.70.BA, 2.NK.70.BA-BL, 2.NK.70.BN-BL, 2.NK.71.BA,
2.NK.71.BA-BL, 2.NK.71.BR-BL
Control of bleeding in small and large intestine1.NP.13.BA-C2, 1.NP.13.BA-KK, 1.NP.13.BA-GX
Table 2 Characteristics of patients admitted to hospital with incidence of gastrointestinal bleeding secondary to peptic ulcer disease n (%)
All hospitalized patients with UGIB Secondary to PUDPatients admitted for UGIB Secondary to PUD
n =7079n = 4713
Female2784 (39.3)1841 (39.1)
Age ≥ 65 yr4307 (60.8)2720 (57.7)
Rural1318 (18.6)883 (18.7)
Underwent upper endoscopy5422 (76.6)3466 (73.5)
Underwent interventional radiology treatment42 (0.6)26 (0.6)
Underwent both interventional radiology and surgery110 (23.8)7 (26.7)
Comorbidities
No comorbidities3016 (42.6)2491 (52.9)
1-2 comorbidities2329 (32.9)1460 (31.0)
≥ 3 comorbidities1734 (24.5)762 (16.2)
In-hospital mortality601/7079 (8.5)175/4722 (3.7)
30-d readmission with UGIB secondary to PUD2301/6478 (4.7)229/4538 (5.1)
Surgical intervention305/7079 (4.3)200/4722 (4.2)
Table 3 Adjusted odds ratio (95%CI) among all hospitalized patients with an gastrointestinal bleeding secondary to peptic ulcer disease; admitted for any cause (n = 7079)
In-hospital mortality (95%CI)30-d readmission (95%CI)1Surgical intervention (95%CI)
One year increase (yr)0.98 (0.94-1.02)1.07 (1.01-1.14)0.98 (0.93-1.04)
Female to male1.28 (1.07-1.53)1.16 (0.91-1.47)0.94 (0.74-1.20)
Age ≥ 65 yr to age < 65 yr1.68 (1.37-2.06)1.57 (1.21-2.04)0.74 (0.58-0.94)
Rural to urban0.90 (0.71-1.14)2.30 (1.79-2.95)0.90 (0.66-1.22)
Perforation to no perforation3.14 (2.03-4.85)1.59 (0.76-3.33)Not applicable
Surgery22.23 (1.56-3.20)1.16 (0.62-2.15)Not applicable
Interventional radiology22.41 (1.07-5.41)0.70 (0.09-5.16)7.18 (3.48-14.84)
Upper endoscopy21.08 (0.86-1.35)0.58 (0.45-0.74)0.86 (0.66-1.13)
Charlson comorbidities3
1-2 comorbidities3.13 (2.36-4.16)1.14 (0.86-1.49)1.07 (0.81-1.41)
≥ 3 comorbidities9.51 (7.28-12.43)1.20 (0.88-1.64)1.04 (0.77-1.41)
Table 4 Adjusted odds ratio (95%CI) among all hospitalized patients with Gastrointestinal bleeding due to gastric or duodenal ulcers (n = 6356)
In-hospital mortality (95%CI)30-d readmission (95%CI)1Surgical intervention (95%CI)
Duodenal vs gastric ulcer1.27 (1.05-1.53)1.54 (1.19-1.99)1.73 (1.34-2.23)
One year increase (yr)0.98 (0.93-1.02)1.08 (1.02-1.15)0.99 (0.93-1.05)
Female to male1.22 (1.01-1.48)1.26 (0.97-1.63)0.96 (0.74-1.24)
Age ≥ 65 yr to age < 65 yr1.65 (1.33-2.05)1.59 (1.20-2.10)0.76 (0.59-0.98)
Rural to urban0.83 (0.64-1.08)2.36 (1.80-3.09)1.00 (0.73-1.38)
Perforation to no perforation2.32 (1.44-3.75)1.29 (0.58-2.84)Not Applicable
Surgery22.52 (1.73-3.68)1.29 (0.69-2.43)Not Applicable
Interventional radiology22.22 (0.99-4.99)0.59 (0.08-4.41)5.74 (2.69-12.27)
Upper endoscopy21.24 (0.96-1.59)0.59 (0.45-0.77)0.77 (0.58-1.01)
Charlson comorbidities3
1-2 comorbidities3.19 (2.35-4.32)1.29 (0.96-1.73)1.06 (0.79-1.41)
≥ 3 comorbidities9.87 (7.42-13.14)1.33 (0.96-1.85)1.00 (0.73-1.37)
Table 5 Adjusted odds ratio (95%CI) among all hospitalized patients where gastrointestinal bleeding secondary to peptic ulcer disease was the primary reason for hospital stay (n = 4713)
In-hospital mortality (95%CI)30-d readmission (95%CI)1Surgical intervention (95%CI)
One year increase (yr)0.96 (0.89-1.04)1.09 (1.02-1.16)0.99 (0.93-1.07)
Female to male1.42 (1.03-1.96)1.02 (0.78-1.35)1.03 (0.76-1.38)
Age ≥ 65 yr to age < 65 yr2.90 (1.90-4.43)1.83 (1.35-2.47)0.78 (0.58-1.06)
Rural to urban0.89 (0.59-1.35)2.35 (1.77-3.14)1.10 (0.77-1.57)
Perforation to no perforation3.70 (2.05-6.69)1.35 (0.60-3.04)
Surgery23.30 (1.89-5.74)1.42 (0.72-2.8)
Interventional radiology24.89 (1.54-15.54)0.88 (0.11-6.7)8.59 (3.54-20.85)
Upper endoscopy20.62 (0.44-0.88)0.71 (0.53-0.95)0.79 (0.58-1.08)
Charlson comorbidities3
1-2 comorbidities2.56 (1.67-3.95)1.22 (0.90-1.66)1.30 (0.94-1.81)
≥ 3 comorbidities6.63 (4.33-10.16)1.33 (0.92-1.94)1.24 (0.83-1.87)
Table 6 Adjusted odds ratio (95%CI) among all hospitalized patients with an gastrointestinal bleeding secondary to peptic ulcer disease and a Canadian Classification of Health Interventions procedural code for an upper endoscopy (n = 5422)
In-hospital mortality30-d readmission1Surgical intervention
One year increase (yr)0.98 (0.94-1.03)1.10 (1.02-1.18)0.98 (0.91-1.05)
Female to male1.35 (1.10-1.64)1.13 (0.84-1.51)0.92 (0.69-1.22)
Age ≥ 65 yr to age < 65 yr1.56 (1.24-1.95)1.70 (1.23-2.36)0.64 (0.49-0.85)
Rural to urban0.90 (0.69-1.17)2.51 (1.85-3.41)0.88 (0.61-1.27)
Perforation to no perforation1.96 (1.08-3.57)1.65 (0.65-4.16)Not Applicable
Surgery22.04 (1.34-3.1)1.64 (0.85-3.18)Not Applicable
Interventional radiology22.30 (0.95-5.55)0.74 (0.10-5.52)5.38 (2.32-12.47)
Charlson comorbidities3
1-2 comorbidities3.21 (2.3-4.47)1.28 (0.92-1.79)1.03 (0.75-1.41)
≥ 3 comorbidities10.32 (7.55-14.1)1.12 (0.76-1.64)1.01 (0.72-1.43)